Intimation under regulation 30- Trading Approval of Equity Shares issued and allotted under Scheme of Amalgamation

September 23, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal Bandra (E), Mumbai-400051 Street Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Sub: Intimation under regulation 30- Trading Approval of Equity Shares issued and allotted under Scheme of Amalgamation Dear Sir/ Ma’am, In terms of Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and in continuation of our earlier intimation dated August 01, 2026, with respect to allotment of 4,45,86,052 equity shares of the company, pursuant to the scheme of Amalgamation sanctioned by Hon’ble National Company Law Tribunal, Chennai Bench(“NCLT”). We wish to inform you that the aforesaid equity shares have been listed and admitted to dealings on the National Stock Exchange of India Limited and BSE Limited with effect from September 23, 2026. You are requested to take the above intimation on record. Thanking You For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Membership No.: F10698